Relmada Therapeutics RLMD
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q2 | 0.60 | -0.30 | -10,221 | -10 | ||
| 2025Q1 | 0.27 | 103.75 | -0.58 | -18,218 | -18 | |
| 2024Q4 | 0.52 | 102.24 | -0.62 | -19,076 | -19 | |
| 2024Q3 | 3.24 | 105.91 | -0.72 | -23,009 | -22 | |
| 2024Q2 | 3.00 | 105.92 | -0.59 | -18,819 | -18 | |
| 2024Q1 | 4.65 | 105.31 | -0.72 | -22,988 | -22 | |
| 2023Q4 | 4.14 | 106.61 | -0.83 | -26,829 | -25 | |
| 2023Q3 | 3.00 | 103.14 | -0.73 | -22,693 | -22 | |
| 2023Q2 | 2.46 | 102.86 | -0.85 | -26,027 | -25 | |
| 2023Q1 | 2.26 | 106.96 | -0.87 | -28,154 | -26 | |
| 2022Q4 | 3.49 | 102.00 | -1.26 | -38,702 | -38 | |
| 2022Q3 | 37.02 | 98.27 | -1.31 | -38,737 | -39 | |
| 2022Q2 | 18.99 | 113.97 | -1.33 | -45,512 | -40 | |
| 2022Q1 | 26.99 | 96.36 | -1.40 | -38,297 | -40 | |
| 2021Q4 | 22.53 | 99.43 | -1.80 | -34,183 | -34 | |
| 2021Q3 | 26.21 | 100.11 | -2.46 | -42,654 | -43 | |
| 2021Q2 | 32.01 | 99.66 | -1.56 | -26,462 | -27 | |
| 2021Q1 | 35.21 | 100.86 | -1.34 | -22,405 | -22 | |
| 2020Q4 | 32.07 | 94.41 | -1.29 | -20,923 | -21 | |
| 2020Q3 | 37.62 | 101.66 | -1.07 | -17,184 | -17 |